Financial Gravity Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-24
| Closed | -$2.18K | – | 1574 |
|
|
2024
Q1 | $2.18K | Sell |
24
-2
| -8% | -$181 | ﹤0.01% | 1063 |
|
|
2023
Q4 | $2.74K | Buy |
26
+13
| +100% | +$1.37K | ﹤0.01% | 942 |
|
|
2023
Q3 | $1.25K | Sell |
13
-74
| -85% | -$7.11K | ﹤0.01% | 743 |
|
|
2023
Q2 | $1.1K | Sell |
87
-10
| -10% | -$126 | ﹤0.01% | 787 |
|
|
2023
Q1 | $1.39K | Sell |
97
-6
| -6% | -$86 | 0.04% | 333 |
|
|
2022
Q4 | $1.39K | Sell |
103
-917
| -90% | -$12.4K | 0.01% | 603 |
|
|
2022
Q3 | $1.22K | Buy |
1,020
+24
| +2% | +$29 | 0.04% | 337 |
|
|
2022
Q2 | $1.19K | Buy |
996
+72
| +8% | +$86 | 0.04% | 308 |
|
|
2022
Q1 | $1.11K | Sell |
924
-220
| -19% | -$263 | 0.03% | 329 |
|
|
2021
Q4 | $1.27K | Buy |
1,144
+1,130
| +8,071% | +$1.26K | 0.03% | 365 |
|
|
2021
Q3 | $77K | Hold |
14
| – | – | 0.04% | 430 |
|
|
2021
Q2 | $83K | Sell |
14
-8
| -36% | -$47.4K | 0.03% | 404 |
|
|
2021
Q1 | $1.67K | Sell |
22
-66
| -75% | -$5.02K | 0.03% | 250 |
|
|
2020
Q4 | $8K | Buy |
+88
| New | +$8K | 0.01% | 193 |
|
|
2020
Q2 | – | Sell |
-574
| Closed | -$48.5K | – | 119 |
|
|
2020
Q1 | $48.5K | Sell |
574
-398
| -41% | -$33.6K | 0.15% | 69 |
|
|
2019
Q4 | $85K | Sell |
972
-488
| -33% | -$42.7K | 0.06% | 389 |
|
|
2019
Q3 | $98K | Sell |
1,460
-330
| -18% | -$22.2K | 0.08% | 211 |
|
|
2019
Q2 | $153K | Sell |
1,790
-377
| -17% | -$32.2K | 0.13% | 178 |
|
|
2019
Q1 | $194K | Buy |
+2,167
| New | +$194K | 0.16% | 140 |
|
|
2018
Q3 | $195K | Sell |
2,081
-101
| -5% | -$9.46K | 0.2% | 122 |
|
|
2018
Q2 | $221K | Sell |
2,182
-185
| -8% | -$18.7K | 0.21% | 97 |
|
|
2018
Q1 | $195K | Buy |
+2,367
| New | +$195K | 0.2% | 96 |
|